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Objective: To evaluate the prevalence of fecal carriage of vancomycin-resistant enterococci (VRE) by patients
hospitalized in intensive care units from 24 French general hospitals.
Methods: Rectal swabs were obtained from 647 patients hospitalized in intensive care units during the month of June
1994 and plated on agar medium selective for vancomycin-resistant enterococci. The glycopeptide resistance
phenotypes and genotypes of the enterococci detected were characterized.
Results: Thirty-two of 647 patients (4.9%) carried VRE. Thirteen strains (2%) were identified as Enterococcus faecium
and 19 (2.9%) as Enterococcus gallinarum or Enterococcus casseliflavus. None of these strains was highly resistant to
gentamicin. The E. ga/linarum and E. casseliflavus strains contained the vanCl and vanC2 genes, respectively. The E.
faecium strains were highly resistant to vancomycin and teicoplanin and carried the vanA gene. No infection due to VRE
was observed during the study period. Pulsed-field gel analysis of total DNA following digestion with Smal or Kspl from
13 VanA-type E. faecium strains revealed intra- and inter-hospital strain heterogeneity. However, the finding of isolates
with indistinguishable pulsed-field types within the same ward and in two medical centers suggests patient-to-patient
transmission or a common source. Four E. faecium strains were isolated within 48 h after admission of patients.
Conclusions: These results indicate that VRE form part of the normal flora of patients and that, despite the actual
scarcity of infections due to VRE, there is a potential risk for dissemination of these strains in French hospitals.
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Many reports have drawn attention to the emerging
problem of vancomycin-resistant enterococci (VRE)
in hospitalized patients [1,2]. VRE are increasingly
isolated in certain hospitals in the UK and the USA,
especially in large, tertiary-care hospitals and in inten-
sive care units (ICUs) [1,3,4]. In the USA, vancomycin
resistance in enterococcal isolates from ICU patients
increased from 0.4% in 1989 to 13.6% in 1993 [1].
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In contrast, the figures are different in most European
countries. Belgian [5] and French [6] multicenter studies
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carried out in 1993 reported low rates of glycopeptide
resistance in enterococci (2.5% and 0.76% respectively),
and only sporadic cases of infection or colonization
have been reported from Italy [7], The Netherlands [81
and Spain [9]. In cases of outbreaks, the source of
enterococci is usually considered to be endogenous,
although patient-to-patient transmission is being
increasingly reported [2, 10-12,13,14]. The patient's
gastrointestinal tract appears to be a reservoir for VRE
[15] and risk factors for acquisition of such strains
include gastrointestinal colonization [16]. We wished to
assess the fecal carriage of VRE in patients in French
general hospitals where VRE infections are rare, to
evaluate the risk for potential hospital dissemination of
these organisms. For this purpose, the prevalence of
fecal carriage ofVRE in the ICUs of24 French general
hospitals was studied and the relationship between the
isolates was analyzed.
MATERIALS AND METHODS
Study design
The study was performed in June 1994 in the ICUs
of 24 general hospitals located in Aix-en-Provence,
Ales, Annemasse, Arras, Aulnay-sous-Bois, Aurillac,
Avranches, Compiegne, Charleville-Mezieres, Le
Havre, Le Havre-Monod, La Roche-sur-Yon, Mantes-
la-Jolie, Meaux, Montceau-Ies-Mines, Montreuil-
sOllS-Bois, Mulhouse, Neufchateau, Paris (Clinique de
la Porte de Choisy), Saint-Brieuc, Saint-Germain-en-
Laye, Villeneuve-Saint-Georges, and Villeneuve sur
Lot. The hospital size varied from 200 to 1600 beds.
The mean number ofICU beds was nine (from four to
20) and the total number 233. The mean duration of
ICU stay was 6.5 days (from 3 to 10.9). In order to
obtain a rectal swab per patient hospitalized in June
1994, the study was performed as follows. First, rectal
swabs were taken from all patients in all the ICUs on
1 June 1994 and transported to the microbiology
laboratory for selective culture ofVRE. Then, a rectal
swab was obtained for all new patients hospitalized in
the ICUs until 30 June 1994. The day of sampling was
chosen as the most convenient for the investigator
between the patient's admission and discharge.
Selective culture and identification of VRE
Samples were plated on bile azide aesculin agar (Sanofi
Diagnostics Pasteur, Marnes la Coquette, France) or on
D coccosel agar (bioMerieux, La-Balme les-Grottes,
France), both supplemented with 8 mg/L of vanco-
mycin. Two control strains were used, E. Jaedum
BM4147, which contains the vanA gene (MIC of
vancomycin: 512 mg/L) [171 and E. Jaedum D366,
which harbors the vanB operon (MIC of vancomycin:
32 mg/L) [18]. Colonies which grew on agar with a
dark brown halo were further identified by Gram
staining, tolerance to tellurite and the API 20 STREP
system (bioMerieux). Motility was searched for on
mannitol motility agar incubated at 30°C for 48 h. The
presence of a pigment was assessed on trypticase soya
agar. Species identification of E. Jaecalis, E. Jaedum, E.
casselifiavus and E. gallinarum was confirmed by specific
PCR amplification of the ddlE.faecali', ddlE.jaedum, vanCl
and vanC2 genes, respectively [19].
Antibiotic susceptibility
MICs ofvancomycin and teicoplanin were determined
by the agar dilution technique in Mueller-Hinton
medium (Sanofi Diagnostics Pasteur). Susceptibility
to ampicillin, erythromycin, ciprofloxacin, gentamicin,
kanamycin and tetracycline was determined by the
disk diffusion technique, using high-content disks for
detection of high-level streptomycin, kanamycin and
gentamicin resistance [20]. The breakpoints used are
those of the CA-SFM [21].
Molecular analysis of VRE
The vanA and vanB resistance genotypes were identified
by PCR, as described [19]. Enterococcal strains, includ-
ing E. jaedum PON from our laboratory collection as
a control, were analyzed by pulsed-field gel electro-
phoresis (pFGE) ofmacrorestriction fragments. Genomic
DNA was prepared in agarose plugs [22], and digested
with Smal or Kspl (Boehringer Mannheim, Germany),
and the DNA fragments generated were separated in a
1.2% agarose gel prepared and run in x 0.5 Tris-
Borate-EDTA buffer in a contour clamped homo-
geneous field apparatus (CHEF-DR2, Biorad, Ivry sur
Seine, France). The parameters for electrophoresis were
200 V for 18 h with pulse times ranging from 5 to 35
s for plugs digested with Smal, and 150 V for 16 h using
mode I 10 s-10 s and then for 8 h using mode II 6 s-6
s for plugs digested with KspI. Isolates having identical
PFGE patterns with the two enzymes were assigned to
the same type, whereas organisms differing by three
restriction fragments or more were considered to be
epidemiologically unrelated [23]. Calculation of Dice
indexes and resulting dendrograms were done using
the software Gel-Compar (Applied Maths, Kortrijk,
Belgium).
RESULTS
Prevalence and characteristics of VRE
Rectal swabs were obtained from 173 patients (95%
of hospitalized patients) on the first day of the survey
and from 474 patients (44% of hospitalized patients)
during the following 29 days. Thirty-two patients
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(4.9%) carried VRE, including 13 E. faecium strains
(2%) and 19 E. gallinarum and E. casselifiavus strains
(2.9%) intrinsically resistant to vancomycin. Species
identification by biochemical tests was in agreement
with that based on PCR. Gene amplification was
particularly useful in a difficult case of identification of
an atypical E. gallinarum strain that did not ferment
raffinose. All E. faecium strains were higWy resistant to
both vancomycin and teicoplanin (MICs ~ 64 mg/L)
and carried the vanA gene, as shown by PCR. Only
one vancomycin-resistant E. faecium strain was resistant
to ampicillin. Six of 13 E. faecium strains were resistant
to high levels of streptomycin and kanamycin but not
to high levels of gentamicin. Most E. faecium strains
were resistant to erythromycin (12/13) and tetracycline
(11113), and none to ciprofloxacin. The 19 strains
of E. gallinarum and E. casselifiavus were moderately
resistant to vancomycin (MICs 8-16 mg/L) and sus-
ceptible to teicoplanin (MICs 0.5-1 mg/L) .
Epidemiology of VanA-type f. faecium
The 13 VarrA-type E. faecium strains were isolated in
eight hospitals (33%). A single E. faecium strain was
isolated in four hospitals, two strains were isolated in
three hospitals, and three strains in one hospital. The
isolates differed in their pulsed-field type, except for
two hospitals (Aix-en-Provence and Villeneuve-Saint-
Georges) where two strains in each displayed closely
related restriction profiles with a Dice index equal
to 95% (Figure 1). In the Villeneuve-Saint-Georges
hospital, located in the suburbs of Paris, two of
the three isolates, obtained from two patients suffering
from asthma and myocardial infarction, respectively,
were indistinguishable by PFGE (Figure 1, lanes 3
and 5). In addition, these latter two strains could not
be distinguished by PFGE after Smai (Figure 1) or KspI
(data not shown) digestion from an isolate from a
Parisian hospital. In all, 10 different clones were
observed (Figure 1). Four of the 13 E. faecium strains
were isolated within 48 h after the patient's admission,
and included, surprisingly, the two clonally related
strains from Villeneuve-Saint-Georges. The two other
strains were isolated from a patient with epilepsy related
to a glioblastoma and a patient with a postpartum
complication. None of these patients had received
antimicrobials prior to hospitalization. A fifth strain was
recovered on the day of a patient's admission for a
cardiac arrest. The patient had been hospitalized for the
10 previous days in another hospital where he was given
perioperative oxacillin prophylaxis for cardiac surgery.
At the time of isolation of the eight remaining strains,
the patients had been hospitalized for from 4 to 44 days.
None of the patients colonized with VRE had received
vancomycin in the ward or during the previous 6
months. The mean duration of hospital stay of VRE
carriers did not significantly differ from that of the
other patients. No VRE were isolated from clinical
specimens during the study period.
DISCUSSION
Despite the fact that our study was carried out in ICUs
where a high incidence ofVRE can be observed [1],
the prevalence of fecal colonization by vancomycin-
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Figure 1 PFGE patterns of Sma I-digested genomic DNA obtained from vancomycin-resistant E. faecium strains.
E. faecium PON (lane 1) was used as a control. Clinical isolates were from the hospitals of Compiegne (lanes 2 and 8),
Villeneuve-Saint-Georges (lanes 3 and 5), Porte de Choisy (lanes 4 and 9), Montreuil-sous-Bois (lane 6), Neufchateau
(lane 7), Aix-en-Provence (lanes 10, 11 and 13), and Avranches (lane 12), Saint-Brieuc (lane 14). Dice indexes are indicated.
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resistant E. faecium was low (2%). In addition, no
infection due to VRE was observed during the study
period. The isolates did not display high-level resistance
to ampicillin and gentamicin in contrast to the majority
of VRE isolated in the USA [3,11]. The figure in
France is similar to that recently reported in a Belgian
university hospital, in which no infection due to VRE
was reported and where 3.5% ofthe patients were VRE
fecal carriers [24]. A 1993 survey in the USA suggested
a relationship between the size of the hospitals and the
incidence of VRE, which was 3.6% in hospitals with
more than 500 beds, as opposed to 1.8% in hospitals
with 200-500 beds and none in hospitals with less than
200 beds [1]. We could not demonstrate any similar
relationship for fecal carriage in patients admitted in
French general hospitals. Close to one third of VRE
were isolated on days 1 or 2 of hospital stay, in the
absence of previous antibiotic therapy. These findings
indicate that these organisms form part of the normal
human fecal flora, and are consistent with the results of
European studies conducted in Belgium, Germany, and
the UK [15,24-26]. Thus, it is not surprising that
PFGE profiles of total DNA of E. faecium showed
diverse restriction patterns. However, the finding of
isolates with indistinguishable PFGE patterns within
the same ward and in two medical centers suggested
patient-to-patient transmission or inter-hospital dis-
semination or a common source. Inter-hospital clonal
transmission ofVRE isolated from clinical samples has
already been reported from certain US medical centers
[14]. However, the fact that two donally related strains
were isolated from two patients on the day ofadmission
in the same hospital favors a common source for these
strains outside hospital. Indeed, the presence of VRE
has recently been reported in the feces of farm animals
and in animal foodstuffs, and a possible source for VRE
could be the food chain [26-29]. Danish and German
authors raised the possibility that the glycopeptide
avoparcin used for nearly 20 years as a feed additive in
animal husbandry in European countries could have
selected for VRE in animals [28,29]. Intrinsically
vancomycin-resistant E. casseliflavus and E. gallinarum
strains were not rare. The vancomycin concentration (8
mg/L) used in the selective medium allowed detection
of strains with MICs greater than or even equal to
8 mg/L. Possibly, certain VanB- or VanC-type entero-
cocci could have been missed because of the low
vancomycin MICs of some of these organisms [19].
Lack of isolation of VanB-type strains in the feces is
probably more related to the rarity of these organisms
in clinical samples in France [6] than to technical
problems, since the selective medium used allowed the
growth of a VanE-type control strain. Because of the
presence ofVRE in the feces ofICU patients, there is
a potential risk for selection and further dissemination
of such organisms in these wards. In particular, ad-
ministration of oral and/or parenteral vancomycin is
frequently reported as a risk factor for infection or
colonization by VRE [2,30] and the extensive use of
this antibiotic in hospitals could strongly contribute
to the selection of these organisms. A recent study
reported that administration of oral vancomycin or
teicoplanin to healthy volunteers led to the selection of
large numbers ofVRE in the fecal flora ofmost of them
[15]. Thus, the use of oral or parenteral vancomycin in
many situations, e.g. routine prophylaxis and selective
digestive tract decontamination, should be discouraged.
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